Publications

Preprints

Synthesis of potent antileukemic quinazoline-thiohydantoin fused heterocycles enabled by metal-free domino reaction. L. Kersting, C. Zippel, L. Herrmann, E.-J. Seo, M. E.M. Saeed, A. Gaube, D. Tailor, A. Dheeraj, S. V. Malhotra, S. Muehlich,T. Efferth, S. B. Tsogoeva. Preprint: ChemRxiv. 2023, https://doi.org/10.26434/chemrxiv-2023-27xgq.
Autocatalytic Double sigma-Bond C(sp2 )–N Transamination Metathesis Reaction. V. Klein, F. Schuster and S. B. Tsogoeva. Preprint: ChemRxiv. 2022, https://doi.org/10.26434/chemrxiv-2022-m6k1v.

2024

153. A domino reaction strategy for facile and modular construction of synthetically challenging functionalized ortho-fluoroanilines. B. W. Grau, S. Kohlbauer, Y. Gu, F. Hahn, J. Lösing, C. Wangen, M. Stangier, L. Ackermann, M. Marschall, and S. B. Tsogoeva. Org. Chem. Front., 2024, DOI: 10.1039/d4qo01692k (Preprint: ChemRxiv. 2024).
152. In-Situ Electrolyte for Electrosynthesis: Scalable Anodically-Enabled One-Pot Sequence from Aldehyde to Isoxazol(in)es. A. A. Al-Romema, H. Xia, K. J. J. Mayrhofer, S. B. Tsogoeva, P. Nikolaienko. Chem. Eur. J., 2024, https://doi.org/10.1002/chem.202402696.
151. Facile synthesis of new antiviral fluoro-quinazolines enabled by merging domino reactions. S. Kohlbauer, H. Xia, B. W. Grau, C. Wangen, F. Hahn, V. G. Nenajdenko, M. Marschall, S. B. Tsogoeva. SYNTHESIS, (dedicated to Professor H. Ila on the occasion of her 80th birthday), 2024, DOI: 10.1055/s-0043-1775411.
150. Privileged Brønsted acid organocatalysis. S. B. Tsogoeva. Nature Catalysis, 2024, 7, 7-9.
149. Synthesis and Photo/Radiation Chemical Characterization of a New Redox-Stable Pyridine-Triazole Ligand. A. A. Al-Romema, F. Plass, A. V. Nizovtsev, A. Kahnt, S. B. Tsogoeva. ChemPhysChem, 2024, https://doi.org/10.1002/cphc.202400273.

148. Characterization of antimalarial activity of artemisinin-based hybrid drugs. C. Quadros, L. Herrmann, J. Manaranche, L. Paloque,M. C.Borges-Silva, G. A. Dziwornu, S. D’Alessandro, K. Chibale, N. Basilico, F. Benoit-Vical, S. B. Tsogoeva, D. R. M. Moreira. Antimicrobial Agents and Chemotherapy, 2024, https://doi.org/10.1128/aac.00143-24.

147. Access to Artemisinin-Triazole Antimalarials via Organo-Click Reaction: High In Vitro/In Vivo Activity Against Multidrug-Resistant Malaria Parasites. L. Herrmann, M. Leidenberger, H. C. Quadros, B. W. Grau, F. Hampel, O. Friedrich, D. R. M. Moreira, B. Kappes, S. B. Tsogoeva. JACS Au, 2024, 4, 951−957 (Cover Picture).

146. Synthesis of New Highly Functionalized Quinolines via Novel Fe(III)-Catalyzed Domino aza-Michael/Aldol/Aromatization Reaction. F. Heckmann, M. M. Ibrahim, F. Hampel, S. B. Tsogoeva. Synlett, 2024, doi: 10.1055/s-0042-1751546.

145. Dipeptide-catalysed Michael reaction under physiological conditions: Examination of potential bioorthogonality. F. Schuster, B. W. Grau, H.-G. Xu, A. Mokhir, S. B. Tsogoeva. Bioorg. Med. Chem. 2024, 103, 117650.

144. Catalytic multi-step domino and one-pot reactions. S. B. Tsogoeva, Beilstein J. Org. Chem. 2024, 20, 254–256.

2023

143. Autofluorescent antimalarials by hybridization of artemisinin and coumarin: In vitro/in vivo studies and live-cell imaging. L. Herrmann, M. Leidenberger, A. S. de Morais, C. Mai, A. Çapci, M. da Cruz Borges Silva, F. Plass, A. Kahnt, D. R. M. Moreira, B. Kappes, S. B. Tsogoeva. Chemical Science. 2023, 14, 12941-12952 (Front Cover, press release).

142. Autofluorescent Artemisinin-Benzimidazole Hybrids via Organo-Click Reaction: Study of Antiviral Properties and Mode of Action in Living Cells. L. Herrmann, F. Hahn, B. W. Grau, M. Wild, A. Niesar, C. Wangen, E. Kataev, M. Marschall, S. B. Tsogoeva. Chem. Eur. J. 2023, 29, e202301194.

141. The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 A ctivity Spanning Variants and Host Cell Types. F. Hahn, C. Wangen, S. Häge, L. Herrmann, A. Herrmann, S. B. Tsogoeva, M. Marschall, Pharmaceutics, 2023, 15, 115.

140. Light-Driven Catalyst-Free Access to Phthalazines: Entry to Antiviral Model Drugs via Merging Domino Reactions in One-Pot. A. Guryev, F. Schuster, L. Herrmann, F. Hahn, C. Wangen, J. Hodek, J. Weber, M. Marschall, S. B. Tsogoeva, Eur. J. Org. Chem., 2023, 26, e202200994 (Front Cover) (Preprint: ChemRxiv. 2022).

2022

139. Iron-Catalyzed Olefin Metathesis: Recent Theoretical and Experimental Advances. B. W. Grau, A. Neuhauser, S. Aghazada, K. Meyer, S. B. Tsogoeva. Chem. Eur. J. 2022, https://doi.org/10.1002/chem.202201414 (Review. Dedicated to the memory of Professor Robert H. Grubbs; Frontispiece).

138. Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection Models. L. Herrmann, F. Hahn, C. Wangen, M. Marschall, S.B. Tsogoeva. Chem. Eur. J. 2022, 28, e202103861 (Front Cover and Cover Profile).

137. Visible Light-driven Metal-free C–H Functionalization: Access to New Bioactive Tetrahydroisoquinoline-Butenolide Hybrids via Domino Amine Oxidation/Vinylogous Mannich Reaction. L. Kersting, L. Kuhn, M. Anokhin, F. Schuster, C. Häberli, S. Sambyal, H. M. Sampath Kumar, J. Keiser, I. Alabugin, S. B. Tsogoeva. ChemPhotoChem, 2022, 6, e202200109 (Front Cover and Cover Profile); (Preprint: ChemRxiv. 2021).

136. Synthesis and In Vitro Study of Artemisinin/Synthetic Peroxide Based Hybrid Compounds against SARS-CoV-2 and Cancer. L. Herrmann, I. A. Yaremenko, A. Çapcı, J. Struwe, D. Tailor, A. Dheeraj, J. Hodek, Y. Y. Belyakova, P. Radulov, J. Weber, S. V. Malhotra, A. O. Terent’ev, L. Ackermann, S. B. Tsogoeva. ChemMedChem, 2022, 17, e202200005 (Preprint: ChemRxiv. 2021).

135. Lewis Acids and Heteropoly Acids in the Synthesis of Organic Peroxides. I. A. Yaremenko, P. S. Radulov, Yu. Yu. Belyakova, D. I. Fomenkov, S. B. Tsogoeva, A. O. Terent’ev. Pharmaceuticals, 2022, 15(4), 472.

2021

134. A Noble Quest for Simplicity in the Chiral World. S. B. Tsogoeva. The New England Journal of Medicine, 2021, 385, 2579-2581.
133. Four-Step Domino Reaction Enables Fully Controlled Non-Statistical Synthesis of Hexaarylbenzene with Six Different Aryl Groups. B. Grau, M. Dill, F. Hampel, A. Kahnt, N. Jux, S. B. Tsogoeva. Angew. Chem. Int. Ed. 2021, 60, 22307-22314 (Hot Paper – Editor’s Choice; Front Cover; Phys.Org.) Preprint: ChemRxiv. 2021).
132. Controlling and Fine-Tuning Charge Transfer Emission in 2,6-Dicyanoaniline Multichromophores Prepared through Domino Reactions: Entry to a Potentially New Class of OLEDs. F. Plass, S. Bönisch, F. Held, T. Ullrich, F. Fischer, A. Guryev, A. Görling, A. Kahnt, S. B. Tsogoeva. J. Org. Chem. 2021, 86, 6111-6125 (Cover Picture).
131. Artemisinin-Derived Dimers from a Chemical Perspective. A. Çapcı, L. Herrmann, H. M. Sampath Kumar, T. Fröhlich, S. B. Tsogoeva. Medicinal Research Reviews, (Special Issue, in honor of Professor Youyou Tu’s 90^th anniversary) 2021, 41, 2927-2970 (Cover Picture).
130. Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity. F. Hahn, S. T. Hamilton, C. Wangen, M. Wild, J. Kicuntod, N. Brückner, J. E. L. Follett, L. Herrmann, A. Kheimar, B. B. Kaufer, W. D. Rawlinson, S. B. Tsogoeva, M. Marschall. Int. J. Mol. Sci. 2021, 22, 12858.
129. Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle. H. C. Quadros, A. Çapcı, L. Herrmann, S. D’Alessandro, D. Fontinha, R. Azevedo, W. Villarreal, N. Basilico, M. Prudêncio, S. B. Tsogoeva, D. R. M. Moreira. Pharmaceuticals, 2021, 14, 1129, https://doi.org/10.3390/ph14111129.
128. The Catalysis of Ring Synthesis. S. B. Tsogoeva, G. Dong, L. Ackermann. ChemCatChem, 2021, 13, 2962-2964.
127. Chemical Hybridization of Sulfasalazine and Dihydroartemisinin Promotes Brain Tumor Cell Death. A. Ackermann, A. Çapcı, M. Buchfelder, S. B. Tsogoeva, N. Savaskan. Scientific Reports, 2021, 11: 20766.
126. Disclosure of Ground State Zimmerman-Möbius Aromaticity in Radical Anion of [6]helicene and Evidence for 4π periodic Aromatic Ring Currents in a molecular “metallic” Möbius Strip. M. Mauksch and S. B. Tsogoeva. Chem. Eur. J. 2021, 27, 14660-14671.
125. Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs). M. Wild, J. Kicuntod, L. Seyler, C. Wangen, L. D. Bertzbach, A. M. Conradie, B. B. Kaufer, S. Wagner, D. Michel, J. Eickhoff, S. B. Tsogoeva, T. Bäuerle, F. Hahn, M. Marschall, Int. J. Mol. Sci. 2021, 22, 575.

2020

124. (Iso)Quinoline-Artemisinin Hybrids via Click Chemistry: Highly Potent Agents against Viruses. A. Çapcı, M. M. Lorion, C. Mai, F. Hahn, J. Hodek, C. Wangen, J. Weber, M. Marschall, L. Ackermann, S. B. Tsogoeva. Chem. Eur. J. 2020, 26, 12019-12026 (Cover Picture).
123. Photoracemization-based Viedma ripening of a BINOL derivative. G. Belletti, C. Tortora, I. D. Mellema, P. Tinnemans, H. Meekes, F. P. J. T. Rutjes, S. B. Tsogoeva, E. Vlieg, Chem. Eur. J. 2020, 26, 839-844 (Hot Paper – Editor’s Choice; Cover Picture).
122. Speeding up Viedma Deracemization through Water catalyzed and Reactant Self-catalyzed Racemization. C. Tortora, C. Mai, F. Cascella, M. Mauksch, A. Seidel-Morgenstern, H. Lorenz, S. B. Tsogoeva. ChemPhysChem, 2020, 21, 1775-1787 (Cover Picture).
121. Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer. T. Fröhlich, C. Mai, R. Bogautdinov, S. N. Morozkina, A. G. Shavva, O. Friedrich, D. Gilbert, S. B. Tsogoeva. ChemMedChem, 2020, 15, 1473-1479.
120. Structural Hybridization as a Facile Approach to New Drug Candidates. H. M. S. Kumar, L. Herrmann, S. B. Tsogoeva. Bioorg. Med. Chem. Lett., (Invited Digest), 2020, 30, 127514.
119. Iron-catalyzed carbonyl metathesis reactions. B. W. Grau, S. B. Tsogoeva, Catalysts, 2020, 1092; https://doi.org/10.3390/catal10091092.
118. The artemisinin-derived autofluorescent compound BG95 exerts strong anticytomegaloviral activity based on a mitochondrial targeting mechanism. M. Wild, F. Hahn, B. Grau, L. Herrmann, A. Niesar, M. Schütz, M. M. Lorion, L. Ackermann, S. B. Tsogoeva, M. Marschall, Int. J. Mol. Sci. 2020, 21, 5578; https://doi.org/10.3390/ijms21155578
117. Target verification of artesunate-related antiviral drugs: Assessing the role of mitochondrial and regulatory proteins by click chemistry and fluorescence labeling. F. Hahn, A. Niesar, C. Wangen, M. Wild, B. Grau, L. Herrmann, A. Çapcı, A. Adrait, Y. Couté, S. B. Tsogoeva, M. Marschall. Antiviral Research, 2020, https://doi.org/10.1016/j.antiviral.2020.104861.
116. The trimeric artesunate derivative TF27 shows therapeutic and prophylactic efficacy against cytomegalovirus upon oral treatment of immunocompetent mice. M. Wild, L. D. Bertzbach, P. Tannig, C. Wangea, R. Müller, L. Herrmann, T. Fröhlich, S. B. Tsogoeva, B. B. Kaufer, M. Marschall, F. Hahn. Antiviral Research, 2020, https://doi.org/10.1016/j.antiviral.2020.104788.
115. A highly potent trimeric derivative of artesunate shows promising treatment profiles in experimental models for congenital HCMV infection in vitro and ex vivo. C. Jacquet, M. Marschall, D. Andouard, C. El Hamel, T. Chianea, S. B. Tsogoeva, S. Hantz, S. Alain. Antiviral Research, 2020, https://doi.org/10.1016/j.antiviral.2019.104700.

2019

114. Artemisinin‐(Iso)Quinoline Hybrids by C‐H Activation and Click Chemistry: Combating Multidrug‐Resistant Malaria. A. Çapcı, M. M. Lorion, H. Wang, N. Simon, M. Leidenberger, M. C. Borges Silva, D. R. M. Moreira, Y. Zhu, Y. Meng, J. Y. Chen, M. Lee, O. Friedrich, B. Kappes, J. Wang, L. Ackermann, S. B. Tsogoeva, Angew. Chem. Int. Ed., 2019, 58, 13066-13079 (Hot Paper – Editor’s Choice; Cover Picture, Highlighted by Nature, Featured in ACIE Special Issue Science Forum 2019), press release.
113. Facile Access to Challenging ortho-Terphenyls via Merging Two Multi-Step Domino Reactions in One-Pot: A Joint Experimental/ Theoretical Study. B. W. Grau, S. Bönisch, A. Neuhauser, F. Hampel, A. Görling, S. B. Tsogoeva, ChemCatChem, 2019, 11, 3982-3992 (Invited Article; Special Issue “Women of Catalysis”).
112. Biomimetic non-heme iron-catalyzed epoxidation of challenging terminal alkenes using aqueous H₂O₂ as an environmentally friendly oxidant. A. Fingerhut, J. Vargas-Caporali, M. Antonio Leyva-Ramírez, E. Juaristi, S. B. Tsogoeva, Molecules, 2019, 24, 3182; doi:10.3390/molecules24173182 (Special Issue “Organic Transformations Promoted by 3d Metal Complexes: Synthetic Applications and Mechanisms”).
111. Combination of 5-Fluorouracil and Thymoquinone Targets Stem Cell Gene Signature in Colorectal Cancer Cells. B. Ndreshkjana, A. Çapci, V. Klein, P. Chanvorachote, J. K. Muenzner, K. Huebner, S. Steinmann, K. Erlenbach-Wünsch, C. I. Geppert, A. Agaimy, F. Ballout, C. El-Baba, H. Gali-Muhtasib, A. Hartmann, S. B. Tsogoeva, R. Schneider-Stock, Cell Death & Disease, 2019, 10:379.
110. Visible‐Light‐Driven C‐H Oxidation of Cyclic Tertiary Amines: Access to Synthetic Strychnos Alkaloids with Antiviral Activity. A. A. Guryev, F. Hahn, M. Marschall, S. B. Tsogoeva. Chem. Eur. J., (dedicated to Professor H. Ila on the occasion of her 75th birthday), 2019, 25, 4062-4066.
109. Hückel and Möbius Aromaticity in Charged Sigma Complexes. M. Mauksch, S. B. Tsogoeva. Chem. Eur. J. (dedicated to Professor Tim Clark on the occasion of his 70th birthday), 2019, 25, 7457-7462.
108. Synthesis of New Betulinic acid/Betulin-derived Dimers and Hybrids with Potent Antimalarial and Antiviral Activities. A. Çapcı Karagöz, M. Leidenberger, F. Hahn, F. Hampel, O. Friedrich, M. Marschall, B. Kappes, S. B. Tsogoeva. Bioorg. Med. Chem. 2019, 27, 110-115.
107. In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model. E. Sonntag, F. Hahn, L. D. Bertzbach, L. Seyler. C. Wangen, R. Müller, P. Tannig, B. Grau, M. Baumann, E. Zent, G. Zischinsky, J. Eickhoff, B. B. Kaufer, T. Bäuerle, S. B. Tsogoeva, M. Marschall. Antiviral Research, 2019, 161, 63-69.
106. Spatial modes of laser-induced mass transfer in microgaps. T. Foertsch, A. T. Davis, R. Popov, C. von Bojničić-Kninski, F. E. Held, S. B. Tsogoeva, F. F. Löffler, A. Nesterov-Mueller, Appl. Sci. 2019, 9, 1303; doi:10.3390/app9071303.

2018

105. Synthesis of artemisinin-derived di/tri-mers and dendrimers, investigation of their activity against P. falciparum and cytomegalovirus, and insights into their mechanisms of action. T. Fröhlich, F. Hahn, L. Belmudes, M. Leidenberger, O. Friedrich, B. Kappes, Y. Couté, M. Marschall, S. B. Tsogoeva. Chem. Eur. J., 2018, 24, 8103-8113 (Hot Paper – Editor’s Choice; Frontispiece, Highlighted in Chemistry Views, 2018).
104. Three-Component Domino Knoevenagel/Vinylogous Michael Reaction: Entry to Challenging o-Terphenyls. D. Grau, B. W. Grau, F. Hampel, S. B. Tsogoeva, Chem. Eur. J., 2018, 24, 6551-6556 (Hot Paper – Editor’s Choice; Frontispiece).
103. Synthesis of artemisinin-estrogen hybrids highly active against HCMV, P. falciparum, cervical and breast cancer. T. Fröhlich, A. Kiss, J. Wolfling, E. Mernyak, Á. E. Kulmány, R. Minorics, I. Zupkó, M. Leidenberger, O. Friedrich, B. Kappes, F. Hahn, M. Marschall, G. Schneider, S. B. Tsogoeva. ACS Med. Chem. Lett., 2018, 9, 1128-1133.
102. Access to new highly potent antileukemia, antiviral and antimalarial agents via hybridization of natural products (homo)egonol, thymoquinone and artemisinin. A. Çapcı Karagöz, C. Reiter, E.-J. Seo, L. Gruber, F. Hahn, M. Leidenberger, V. Klein, F. Hampel, O. Friedrich, M. Marschall, B. Kappes, T. Efferth, S. B. Tsogoeva. Bioorg. Med. Chem. 2018, 26, 3610-3618.
101. Spin-paired Solvated Electron Couples in Alkali-Ammonia Systems. M. Mauksch and S. B. Tsogoeva, Phys. Chem. Chem. Phys. (PCCP), 2018, 20, 27740-27744.
100. Strict Correlation of HOMO Topology and Magnetic Aromaticity Indices in d‐Block Metalloaromatics. M. Mauksch, S. B. Tsogoeva. Chem. Eur. J., 2018, 24, 10059-10063.
99. Novel fully organic water oxidation electrocatalysts: A quest for simplicity. Y. Wu, V. Klein, M. S. Killian, C. Behling, S. Chea, S. B. Tsogoeva, J. Bachmann. ACS Omega, 2018, 3, 2602-2608.
98. Synthesis of Thymoquinone–Artemisinin Hybrids: New Potent Antileukemia, Antiviral, and Antimalarial Agents. T. Fröhlich, C. Reiter, M. E. M. Saeed, C. Hutterer, F. Hahn, M. Leidenberger, O. Friedrich, B. Kappes, M. Marschall, T. Efferth, S. B. Tsogoeva, ACS Med. Chem. Lett., 2018, 9, 534-539.
97. Artesunate-derived monomeric, dimeric and trimeric experimental drugs – their unique mechanistic basis and pronounced antiherpesviral activity. F. Hahn, T. Fröhlich, T. Frank, L. D. Bertzbach, S. Kohrt, B. B. Kaufer, T. Stamminger, S. B. Tsogoeva, M. Marschall, Antiviral Research, 2018, 152, 104-110.
96. Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds. L. Gruber, S. Abdelfatah, T. Fröhlich, C. Reiter, V. Klein, S. B. Tsogoeva, T. Efferth. Molecules, 2018, 23, 841; DOI: 10.3390/molecules23040841.

2017

95. Facile access to potent antiviral quinazoline heterocycles with fluorescence properties via merging metal-free domino reactions. F. E. Held, A. A. Guryev, T. Fröhlich, F. Hampel, A. Kahnt, C. Hutterer, M. Steingruber, H. Bahsi, C. von Bojničić-Kninski, D. S. Mattes, T. C. Foertsch, A. Nesterov-Mueller, M. Marschall, S. B. Tsogoeva, Nature Commun., 2017, 8: 15071 (Highlighted by Nature Commun. in “Synthetic and Medicinal Chemistry” Themed Collection; Featured by Science Magazine; Research in Germany; Science Newsline; Technology Networks; EurekAlert! Science News; Phys.Org; Health Medicinet; Jura Forum; Bionity.com).
94. Deeper Insight into the Six-Step Domino Reaction of Aldehydes with Malononitrile and Evaluation of Antiviral and Antimalarial Activities of the Obtained Bicyclic Products. C. M. Bock, G. Parameshwarappa, S. Bönisch, W. Bauer, C. Hutterer, M. Leidenberger, O. Friedrich, M. Marschall, B. Kappes, A. Görling, S. B. Tsogoeva. ChemistryOpen, 2017, 6, 364-374 (Cover Picture).
93. Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities Against Plasmodium falciparum, Human Cytomegalovirus and Leukemia Cells. T. Fröhlich, C. Reiter, M. M. Ibrahim, J. Beutel, C. Hutterer, I. Zeitträger, H. Bahsi, M. Leidenberger, O. Friedrich, B. Kappes, T. Efferth, M.Marschall, S. B. Tsogoeva, ACS Omega, 2017, 2, 2422-2431.
92. Iron-catalyzed olefin metathesis with low-valent iron alkylidenes. M. Mauksch and S. B. Tsogoeva. Chem. Eur. J. (paper dedicated to Professor Roald Hoffmann on occasion of his 80th birthday), 2017, 23, 10264-10269.
91. Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas. A. Ackermann, A. Çapcı Karagöz, A. Ghoochani, M. Buchfelder, I. Eyüpoglu, S. B. Tsogoeva, N. Savaskan, Oncotarget, 2017, DOI: 10.18632/oncotarget.18390.
90. 4N electron aromatic cycles in polycyclic hydrocarbons. M. Mauksch and S. B. Tsogoeva, Phys. Chem. Chem. Phys. (PCCP), 2017, 19, 14066-14072.
89. Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer. T. Fröhlich, B. Ndreshkjana, J. K. Muenzner, C. Reiter, E. Hofmeister, S. Mederer, M. Fatfat, C. El-Baba, H. Gali‑Muhtasib, R. Schneider-Stock, S. B. Tsogoeva. ChemMedChem, 2017, 12, 226-234.
88. Synthesis of (R)-modafinil via organo- and non-heme iron-catalyzed sulfoxidation using hydrogen peroxide as environmentally benign oxidant. F. E. Held, K.A. Stingl, S. B. Tsogoeva. SYMMETRY, 2017, 9(6), 88; DOI: 10.3390/sym9060088 (Cover Picture).
87. A new architecture of high spin organics based on Baird’s rule of 4n electron triplet aromatics. M. Mauksch and S. B. Tsogoeva, Phys. Chem. Chem. Phys. (PCCP), 2017, 19, 4688-4694 (Featured by Advances in Engineering).
86. Synthesis of Substituted 1,2,3-Triazoles via Metal-Free Click Cycloaddition Reactions and Alternative Cyclization Methods. H. B. Jalani, A. Çapcı Karagöz, S. B. Tsogoeva. SYNTHESIS (Special Issue to celebrate the 70th birthday of Professor Dieter Enders), 2017, 49, 29-41.

2016

85. Generation of Complex Azabicycles and Carbobicycles from Two Simple Compounds in a Single Operation via a Metal-Free Six-Step Domino Reaction. C. M. Bock, G. Parameshwarappa, S. Bönisch, C. Neiss, W. Bauer, F. Hampel, A. Görling, S. B. Tsogoeva, Chem. Eur. J. (paper dedicated to Professor Lutz F. Tietze), 2016, 22, 5189-5197 (Hot Paper – Editor’s Choice; Cover Picture; see also the Feature ARTICLE).
84. Artemisinin-Derived Dimers: Potent Antimalarial and Anticancer Agents. T. Fröhlich, A. Çapci Karagöz, C. Reiter, S. B. Tsogoeva, J. Med. Chem. (Invited Perspective), 2016, 59, 7360-7388.
83. In Vivo and In Vitro Optimization of Screening Antimalarial Hits toward Lead Molecules for Preclinical Development. T. Fröhlich and S. B. Tsogoeva, J. Med. Chem. (Invited Viewpoint), 2016, 59, 9668-9671.
82. Duality of orbital symmetry allowed transition states for thermal sigmatropic hydrogen shifts in transition metal compounds. M. Mauksch and S. B. Tsogoeva. Chem. Eur. J. (paper dedicated to the memory of Professor Yves Chauvin), 2016, 22, 13916-13926.
81. Reversal of orbital symmetry control in electrocyclic ring closures through Craig-Möbius aromaticity. M. Mauksch and S. B. Tsogoeva, ChemPhysChem (paper dedicated to Prof. K. Peter C. Vollhardt on the occasion of his 70th birthday), 2016, 17, 963-966.
80. Synthesis and Electrochemical and Photophysical Characterization of New 4,4’-π-Conjugated 2,2’-Bipyridines that are End-Capped with Cyanoacrylic Acid/Ester Groups. A. Fingerhut, Y. Wu, A. Kahnt, J. Bachmann, S. B. Tsogoeva, Chemistry – An Asian Journal, 2016, 11, 1232-1239 (Highlighted in “Top-Beiträge aus unseren Schwesterzeitschriften” Angew. Chem., 2016, 128, 5720–5723).
79. Asymmetric cycloaddition reactions catalyzed by bifunctional thiourea and squaramide organocatalysts: Recent advances. F. E. Held, S. B. Tsogoeva. Catalysis Science & Technology, 2016, 6, 645-667 (among most accessed articles in 2016).

2015

78. The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65. C. Hutterer, I. Niemann, J. Milbradt, T. Fröhlich, C. Reiter, O. Kadioglu, H. Bahsi, I. Zeitträger, S. Wagner, J. Einsiedel, P. Gmeiner, N. Vogel, S. Wandinger, K. Godl, T. Stamminger, T. Efferth, S. B. Tsogoeva, M. Marschall. Antiviral Research, 2015, 124, 101-109.

77. Highly potent artemisinin derived dimers and trimers: Synthesis and evaluation of their antimalaria, antileukemia and antiviral activities. C. Reiter, T. Fröhlich, L. Gruber, C. Hutterer, M. Marschall, C. Voigtländer, O. Friedrich, B. Kappes, T. Efferth, S. B. Tsogoeva, Bioorg. Med. Chem. 2015, 23, 5452-5458.

76. Enantioselective cycloaddition reactions catalyzed by BINOL-derived phosphoric acids and N-triflyl phosphoramides: Recent advances. F. E. Held, D. Grau, S. B. Tsogoeva, Molecules, 2015, 20, 16103-16126. (Invited Review in a Special Issue “Organocatalysis 2015”).

75. “Peptides as asymmetric organocatalysts.” A. Fingerhut, D. Grau, S. B. Tsogoeva. Book Chapter in “Sustainable Catalysis,” M. North (Ed.), RSC, 2015, Vol. 2, Chapter 13, 309-353. (Dedicated to Professor Eusebio Juaristi on the occasion of his 65th birthday).
74. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4‑trioxane-ferrocene hybrids. C. Reiter, T. Fröhlich, M. Zeino, M. Marschall, H. Bahsi, M. Leidenberger, O. Friedrich, B. Kappes, F. Hampel, T. Efferth, S. B. Tsogoeva. Eur. J. Med. Chem., 2015, 97, 164-172.
73. Non-heme iron catalysts for epoxidation and aziridination reactions of challenging terminal alkenes: Towards sustainability. A. Fingerhut, O. V. Serdyuk, S. B. Tsogoeva. Green Chem., 2015, 17, 2042-2058. (Invited Critical Review. Dedicated to Professor Hisashi Yamamoto on the occasion of his 72th birthday, among most accessed articles in 2015).
72. One-pot synthesis of (R)-convolutamydine A involving in situ chiral organocatalyst formation. S.-W. Wei, B. Schmid, F. Z. Macaev, S. N. Curlat, A. V. Malkov, S. B. Tsogoeva. Asymmetric Catal. 2015, 2, 1-6.

2004 – 2014

71. Michael Addition of N-unprotected 2-Oxindoles to Nitrostyrene Catalyzed by Bifunctional Tertiary Amines: Crucial role of dispersion interactions. C. Reiter, S. López-Molina, B. Schmid, C. Neiss, A. Görling, S. B. Tsogoeva. ChemCatChem, 2014, 6, 1324-1332. (Featured in Chem. Eur. J. 2014, 19, 7542-7545, SPOTLIGHTS, Highlighted in ChemInform, 2014, Vol. 45, Issue 40).
70. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. C. Reiter, A. Çapci Karagöz, T. Fröhlich, V. Klein, M. Zeino, K. Viertel, J. Held, B. Mordmüller, S. Emirdağ Öztürk, H. Anil, T. Efferth, S. B. Tsogoeva. Eur. J. Med. Chem., 2014, 75, 403-412 (TOP 1 among TOP 20 Articles in the Domain of Article 24561670, since 2014, BioMedLib), View AudioSlides.
69. One-Pot Route to beta-Adrenergic Blockers via Enantioselective Organocatalysed Epoxidation of Terminal Alkenes as a Key Step. F. E. Held, S.-W. Wei, K. Eder, S. B. Tsogoeva. RSC Advances, 2014, 4, 32796-32801 (Highlighted in ChemInform, 2015, Vol. 46, Issue 8).
68. α-Nitro Epoxides in Organic Synthesis: Development of a One-Pot Organocatalytic Strategy for the Synthesis of Quinoxalines. M. M. Ibrahim, D. Grau, F. Hampel, S. B. Tsogoeva. Eur. J. Org. Chem., 2014, 1401-1405 (Highlighted in ChemInform, 2014, Vol. 45, Issue 48).
67. Bifunctional Primary Amine-Thioureas in Asymmetric Organocatalysis. O. V. Serdyuk, C. M. Heckel, S. B. Tsogoeva. Org. Biomol. Chem. (Invited Perspective) 2013, 11, 7051-7071 (Most accessed 10/2013; Highlighted in ChemInform, 2013, Vol. 44, Issue 52; TOP 1 among TOP 20 Articles in the Domain of Article 24057617, since 2013, BioMedLib).
66. Combining in situ Generated Chiral Silicon Lewis Acid and Chiral Brønsted Acid Catalysts for [3+2] Cycloadditions: Cooperative Catalysis as a Convenient Enantioselective Route to Pyrazolidines. O. V. Serdyuk, A. Zamfir, F. Hampel, S. B. Tsogoeva. Adv. Synth. Catal., 2012, 354, 3115-3121 (Most accessed 10/2012; Highlighted in ChemInform, 2013, Vol. 44, Issue 15).
65. Insights into the spontaneous emergence of enantioselectivity in an asymmetric Mannich reaction carried out without external catalyst. F. E. Held, A. Fingerhut, S. B. Tsogoeva. Tetrahedron: Asymmetry, 2012, 23, 1663-1669 (Most accessed 03/2013).
64. Synthesis and evaluation of new guanidine-thiourea organocatalyst for the nitro-Michael reaction: Theoretical studies on mechanism and enantioselectivity. T. E. Shubina, M. Freund, S. Schenker, T. Clark, S. B. Tsogoeva. Beilstein J. Org. Chem. (Invited Article: Thematic Series “Organocatalysis” edited by B. List), 2012, 8, 1485-1498.
63. Convenient One-Pot Two-Step Synthesis of 1,3-Thiazoles via Organocatalyzed Epoxidation of Nitroolefins. S.-W. Wei, K. M. Weiß, S. B. Tsogoeva, Synthesis (Invited Article: Practical Synthetic Procedures), 2012, 44, 3441-3446. (Highlighted in ChemInform, 2013, Vol. 44, Issue 13).
62. New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells. C. Reiter, A. Herrmann, A. Çapci, T. Efferth, S. B. Tsogoeva. Bioorg. Med. Chem. 2012, 20, 5637-5641.
61. Asymmetric Vanadium- and Iron-Catalyzed Oxidations: New Mild (R)-Modafinil Synthesis and Formation of Epoxides using aqueous H₂O₂ as a terminal oxidant. K. A. Stingl, K. M. Weiß, S. B. Tsogoeva, Tetrahedron, 2012, 68, 8493-8501.
60. Asymmetric Synthesis of beta-Adrenergic Blockers via Multi-step One-Pot Transformations involving in situ Chiral Organocatalyst Formation. S.-W. Wei, R. Messerer, S. B. Tsogoeva. Chem. Eur. J. 2011, 17, 14380-14384. (Highlighted in Noteworthy Chemistry, weekly feature by ACS, January 9, 2012; Highlighted in SYNFACTS, 2012 , 8, 238).
59. Assessment of Popular DFT and Semiempirical Molecular Orbital Techniques for Calculating Relative Transition State Energies and Kinetic Product Distributions in Enantioselective Organocatalytic Reactions. S. Schenker, C. Schneider, S. B. Tsogoeva, T. Clark, J. Chem. Theor. Comput., 2011, 7, 3586-3595.
58. L-Proline Catalyzed Asymmetric Michael Addition of 2-Oxindoles to Enones: A Convenient Access to Oxindoles with a Quaternary Stereocenter. M. H. Freund, S. B. Tsogoeva. Synlett: Cluster (Invited Article), 2011, 503-507.
57. Enantioselective Epoxidation of Electron-Deficient Olefins: An Organocatalytic Approach. K. M. Weiß and S. B. Tsogoeva. The Chemical Record (Invited Perspective. Dedicated to Prof. Andreas Hirsch on the occasion of his 50th birthday), 2011, 11, 18-39. (Among Hottest articles in Organic Chemistry. Most accessed 3/2011-11/2012; Highlighted in ChemInform, 2011, Vol. 42, Issue 32; Highlighted in the Editorial: Beyond Borders, Beyond Reviews).
56. Binaphthyl-Derived Mono-, Bi- and Multi-functional Lewis and Brønsted Base Organocatalysts: A New Vista for Asymmetric Synthesis. M. Freund, S. Schenker, A. Zamfir and S. B. Tsogoeva. Curr. Org. Chem. (Invited Review in a Special Issue “Fundamentals in Organocatalysis. Past, Present and Future”), 2011, 15, 2282-2310.
55. “Life’s Single Chirality: Origin of Symmetry Breaking in Biomolecules.” M. Mauksch and S. B. Tsogoeva. Book Chapter in “Biomimetic Organic Synthesis,” E. Poupon / B. Nay (Eds.), WILEY-VCH, 2011, Vol. 2, 823-846.
54. Silicon Lewis Acid Catalyzed [3+2] Cycloaddition Reactions of Hydrazones/Cyclopentadiene: Novel Mild Access to Pyrazolidine Derivatives. A. Zamfir, S. Schenker, W. Bauer, T. Clark and S. B. Tsogoeva. Eur. J. Org. Chem., (Invited Communication in a Special Issue: Women in Chemistry, Profiles), 2011, 3706-3709. (Highlighted in ChemInform, 2011, Vol. 42, Issue 49).
53. Novel one-pot process for the synthesis of 1,3-thiazoles via organocatalysed epoxidation of nitro-olefins. K. M. Weiß, S.-W. Wei, S. B. Tsogoeva. Org. Biomol. Chem. 2011, 9, 3457-3461. (Highlighted in SYNFACTS, 2011, 6, 595).
52. Developments in Chiral Binaphthyl-Derived Brønsted / Lewis Acids and Hydrogen-Bond Donor Organocatalysis. S. Schenker, A. Zamfir, M. Freund, S. B. Tsogoeva. Eur. J. Org. Chem., (Invited Microreview), 2011, 2209-2222 (Most accessed 2/2011-1/2012; Highlighted in ChemInform, 2011, Vol. 42, Issue 35).
51. “Peptides for asymmetric catalysis.“ M. Freund and S. B. Tsogoeva. Book Chapter in “Catalytic Methods in Asymmetric Synthesis: Advanced Materials, Techniques, and Applications,” M. Gruttadauria / F. Giacalone (Eds.), John WILEY & Sons, 2011, Chapter 13, 529-578 (Highlighted in ChemInform, 2012, Vol. 43, Issue 20).
50. T owards a Catalytic Asymmetric Version of the [3+2] Cycloaddition Between Hydrazones and Cyclopentadiene. A. Zamfir, S. B. Tsogoeva. Synthesis (Invited Article), 2011, 1988-1992. (Highlighted in ChemInform, 2011, Vol. 42, Issue 46).
49. Asymmetric Hydrocyanation of Hydrazones Catalyzed by in situ Formed O-silylated BINOL-Phosphate: A Convenient Access to Versatile α-Hydrazino Acids. A. Zamfir, S. B. Tsogoeva. Org. Lett. (paper dedicated to Prof. Rolf W. Saalfrank on the occasion of his 70th birthday), 2010, 12, 188-191.
48. When chiral product and catalyst are the same: Discovery of asymmetric organoautocatalysis. S. B. Tsogoeva. Chem. Commun. (Invited Feature Article) 2010, 46, 7662-7669 (Highlighted in ChemInform, 2011, Vol. 42, Issue 6).
47. Bifunctional Organocatalysis with N-Formyl-L-Proline: A Novel Approach to Epoxide Ring Opening and Sulfide Oxidation . S.-W. Wei, K. A. Stingl, K. M. Weiß, S. B. Tsogoeva. Synlett (Invited Article), 2010, 707-711.
46. A Novel Five-coordinate Mn Complex with a Redox-active SNNNS Ligand System. K. Dürr, D. A. Yalalov, F. W. Heinemann, S. B. Tsogoeva, I. Ivanovic-Burmazovic. Z. Naturforsch. B (paper dedicated to Prof. Rolf W. Saalfrank on the occasion of his 70th birthday), 2010, 65b, 258-262.45.
45. Spontaneous Mirror Symmetry Breaking in the Aldol Reaction and its Potential Relevance in Prebiotic Chemistry. M. Mauksch, S.-W. Wei, M. Freund, A. Zamfir, S. B. Tsogoeva. Origins of Life and Evolution of Biospheres, 2010, 40, 79-91.
44. Recent Progress in the Development of Synthetic Hybrids of Natural or Unnatural Bioactive Compounds for Medicinal Chemistry. S. B. Tsogoeva. Mini Rev. Med. Chem., (Invited Review) 2010, 10(9), 773-793.
43. Cytotoxicity of Artesunic Acid Homo- and Heterodimer Molecules towards Sensitive and Multidrug-Resistant CCRF-CEM Leukemia Cells. C. Horwedel, S. B. Tsogoeva, S.-W. Wei, T. Efferth. J. Med. Chem. 2010, 53, 4842–4848.
42. Recent Advances in Sulfoxidation Reactions: A Metal-free Approach. K. A. Stingl, S. B. Tsogoeva. Tetrahedron: Asymmetry (special issue to celebrate the 80th birthday of Professor Henri Kagan), 2010, 21, 1055-1074 (Highlighted in ChemInform, 2010, Vol. 41, Issue 48).
41. Demonstration of “Möbius” Aromaticity in Planar Metallacycles. M. Mauksch, S. B. Tsogoeva. Chem. Eur. J. (paper dedicated to Prof. Paul von Ragué Schleyer on the occasion of his 80th birthday), 2010, 16, 7843-7851.
40. Organoautocatalysis: Challenges for Experiment and Theory. S. B. Tsogoeva. Journal of Systems Chemistry, 2010, 1:8 (Highly Accessed; Highlighted in ChemInform, 2011, Vol. 42, Issue 48).
39. Chiral BINOL-derived phosphoric acids: Privileged Brønsted acid organocatalysts for C-C bond formation reactions. A. Zamfir, S. Schenker, M. Freund and S. B. Tsogoeva. Org. Biomol. Chem. (Invited Perspective), 2010, 8, 5262-5276 (Highlighted in ChemInform, 2011, Vol. 42, Issue 12; Most accessed 9/2010, Front Cover).
38. Generation of Highly Enantioenriched Crystalline Products in Reversible Asymmetric Reactions with Racemic or Achiral Catalysts. S. B. Tsogoeva, S.-W. Wei, M. Freund, M. Mauksch. Angew. Chem. Int. Ed. 2009, 48, 590-594; Angew. Chem. 2009, 121, 598-602 (see also: Chemical & Engineering News, March 23, 2009/ V. 87, PP. 38-41).
37. A Preferred Disrotatory 4n Electron Möbius Aromatic Transition State for a Thermal Electrocyclic Reaction. M. Mauksch, S. B. Tsogoeva. Angew. Chem. Int. Ed. 2009, 48, 2959-2963; Angew. Chem. 2009, 121, 3003-3007.
36. Autocatalytic Enantiomerization at the Crystal Surface in Derazemisation of Scalemic Conglomerates. S.-W. Wei, M. Mauksch, S. B. Tsogoeva. Chem. Eur. J. 2009, 15, 10255-10262.
35. Enantioselective nitro-Michael reactions catalyzed by short peptides on water. M. Freund, S. Schenker, S. B. Tsogoeva. Org. Biomol. Chem. 2009, 7, 4279-4284.
34. Evidence for an Enol Mechanism in a Highly Enantioselective Mannich-type Reaction Catalyzed by Primary Amine-Thiourea. D. A. Yalalov, S. B. Tsogoeva, T. E. Shubina, I. M. Martynova, T. Clark. Angew. Chem. Int. Ed. 2008, 47, 6624-6628; Angew. Chem. 2008, 120, 6726-6730. (Highlighted in ChemInform, 2008, Vol. 39, Issue 50).
33. Spontaneous Emergence of Homochirality via Coherently Coupled Antagonistic and Reversible Reaction Cycles. M. Mauksch, S. B. Tsogoeva. ChemPhysChem. 2008, 9, 2359-2371. (Highlighted in Pharmacy Research Today , 2008, Volume 4, Issue 11).
32. Highly enantioselective organocatalytic formation of quaternary carbon center via chiral Brønsted acid catalyzed self-coupling of enamides. C. Baudequin, A. Zamfir, S. B. Tsogoeva. Chem. Commun. 2008, 4637-4639.
31. Neutral Möbius Aromatics: Derivatives of the Pyrrol Congener Aza[11]annulene as promising Synthetic Targets. M. Mauksch, S. B. Tsogoeva. Eur. J. Org. Chem. (paper dedicated to Professor Edgar Heilbronner), 2008, 5755-5763.
30. Recent Advances in Asymmetric Organocatalytic 1,4-Conjugate Additions. S. B. Tsogoeva. Eur. J. Org. Chem. 2007, 1701-1716 (Invited Microreview, Most-cited article of all articles published in 2007 in the subject category “Chemistry, Organic”,500 citations, ISI Web of Science, 30.01.2012), Most Popular Addition – Most Cited Article, Highlighted in ChemInform, 2007, Vol. 38, Issue 27; Highlighted in Chemistry Views, 2012.
29. Evidence of Asymmetric Autocatalysis in Organocatalytic Reactions. M. Mauksch, S. B. Tsogoeva, I. M. Martynova, S.-W. Wei. Angew. Chem. Int. Ed. 2007, 46, 393-396; Angew. Chem. 2007, 119, 397-400. (Hot Paper – Editor’s Choice; Highlighted in SYNFORM Issue 2007/01; Synlett, Issue 8, 2007; and in Organic Process Research & Development, 2007 , Vol. 11, No. 3, p. 301. Paper dedicated to Professor Lutz F. Tietze on the occasion of his 65th birthday).
28. New highly enantioselective thiourea-based bifunctional organocatalysts for nitro-Michael addition reactions. S.-W. Wei, D. A. Yalalov, S. B. Tsogoeva, S. Schmatz. Catalysis Today. 2007, 121, 151-157.
27. Organocatalysis with chiral formamides: Asymmetric Allylation and Reduction of Imines. C. Baudequin, D. Chaturvedi, S. B. Tsogoeva. Eur. J. Org. Chem. 2007, 2623-2629 (Highlighted in ChemInform, 2007, Vol. 38, Issue 38).
26. Demonstration of Spontaneous Chiral Symmetry Breaking in Asymmetric Mannich and Aldol Reactions. M. Mauksch, S. B. Tsogoeva, S.-W. Wei, I. M. Martynova. Chirality, 2007, 19, 816-825.
25. First enantioselective organocatalytic allylation of simple aldimines with allyltrichlorosilane. S. B. Jagtap, S. B. Tsogoeva. Chem. Commun. 2006, 4747. (Highlighted in ChemInform, 2007, Vol. 38, Issue 13).
24. Highly enantioselective addition of ketones to nitroolefins catalyzed by new thiourea-amine bifunctional organocatalysts. S. B. Tsogoeva, S.-W. Wei. Chem. Commun. 2006, 1451. (Highlighted in ChemInform, 2006, Vol. 37, Issue 32).
23. 4-trans-Amino-proline based di- and tetrapeptides as organic catalysts for asymmetric C-C bond formation reactions. S. B. Tsogoeva, S. B. Jagtap, Z. A. Ardemasova. Tetrahedron: Asymmetry. 2006, 17, 989. (Among TOP25 Articles in 2006; Highlighted in ChemInform, 2006, Vol. 37, Issue 37).
22. Chiral Thiourea-Based Bifunctional Organocatalysts in the Asymmetric Nitro-Michael Addition: A Joint Experimental-Theoretical Study. D. A. Yalalov, S. B. Tsogoeva, S. Schmatz. Adv. Synth. Catal. 2006, 348, 826.
21. “Asymmetric Organocatalysis. From Biomimetic Concepts to Applications in Asymmetric Synthesis”(Book Review) (by A. Berkessel and H. Gröger. Wiley-VCH, Weinheim 2005). S. B. Tsogoeva. Synthesis. 2006, 736.
20. Asymmetric Organocatalysis with Novel Chiral Thiourea Derivatives: Bifunctional Catalysts for the Strecker and nitro-Michael Reactions. S. B. Tsogoeva, D. A. Yalalov, M. J. Hateley, C. Weckbecker, K. Huthmacher. Eur. J. Org. Chem. 2005, 4995. (Among TOP10 most accessed articles in 10/2005; among most accessed articles in 2006; Highlighted in ChemInform, 2006, Vol. 37, Issue 12).
19. “Transition Metals for Organic Synthesis. Building Blocks and Fine Chemicals”(Book Review) (M. Beller and C. Bolm (Ed.). Wiley-VCH, Weinheim 2004). S. B. Tsogoeva. Angew. Chem. Int. Ed. 2005, 44, 3337; Angew. Chem. 2005, 117, 3401.
18. Thiourea-based Non-nucleoside Inhibitors of HIV Reverse Transcriptase as Bifunctional Organocatalysts in the Asymmetric Strecker Synthesis. S. B. Tsogoeva, M. J. Hateley, D. A. Yalalov, K. Meindl, C. Weckbecker, K. Huthmacher. Bioorg. Med. Chem. 2005, 13, 5680.
17. (S)-Histidine-based Dipeptides as Organic Catalysts for Direct Asymmetric Aldol Reactions. S. B. Tsogoeva, S.-W. Wei. Tetrahedron: Asymmetry, 2005, 16, 1947. (Has been recognised with the “Most Cited Paper 2005-2008 Award”; Highlighted in ChemInform, 2005, Vol. 36, Issue 43).
16. Short Peptides and Peptide-Like Enzyme Mimics – Efficient Organic Catalysts in Asymmetric Synthesis. S. B. Tsogoeva. Letters in Organic Chemistry, 2005, 2, 208. (Invited Review, Highlighted in ChemInform, 2006, Vol. 37, Issue 6).
15. Dual Catalyst Control in the chiral Diamine-Dipeptide-Catalyzed Asymmetric Michael Addition. S. B. Tsogoeva, S. B. Jagtap. Synlett. 2004, 2624.
14. Trends in Asymmetric Michael Reactions Catalysed by Tripeptides in Combination with an Achiral Additive in Different Solvents. S. B. Tsogoeva, S. B. Jagtap, Z. A. Ardemasova, V. N. Kalikhevich. Eur. J. Org. Chem. 2004, 4014. (Highlighted in ChemInform, 2005, Vol. 36, Issue 4).

1998 – 2003

13. C2-Chiral Bis(Amidinium)-Catalyst for a Diels-Alder Reaction Constituting the Key Step of the Quinkert-Dane Estrone Synthesis. S. B. Tsogoeva, G. Dürner, M. Bolte, M. W. Göbel. Eur. J. Org. Chem. 2003, 1661.
12. Juliá-Colonna Asymmetric Epoxidation in a Continuously Operated Chemzyme Membrane Reactor. S. B. Tsogoeva, J. Wöltinger, C. Jost, D. Reichert, A. Kühnle, H.-P. Krimmer, K.-H. Drauz. Synlett. 2002, 707.
11. A study of the binding of estradiol and 8-isoestradiol to the estrogen α-receptor by molecular modeling . A. G. Shavva, K. V. Vlasova, S. B. Tsogoeva, M. S. Egorov, P. P. Yakutseni. Russian Journal of Bioorganic Chemistry. 2002, 28, 209.
10. A study of the binding of estradiol and 8-isoestradiol to the estrogen α-receptor by molecular modeling . A. G. Shavva, K. V. Vlasova, S. B. Tsogoeva, M. S. Egorov, P. P. Yakutseni. Bioorganicheskaia Khimiia, 2002, 28, 240.
9. Molecular model of binding of estradiol and 8-isoestradiol with estrogen alpha-receptor. A. G. Shavva, K. V. Vlasova, S. B. Tsogoeva, M. S. Egorov, P. P. Iakutseni. Bioorganicheskaia Khimiia, 2002, 28, 236.
8. Molecular structures of some 8-isoanalogues of steroid estrogens. G. L. Starova, I. I. Eliseev, Sh. N. Abusalimov, S. B. Tsogoeva, A. G. Shavva. Kristallografiya, 2001, 46, 72.
7. Molecular structures of some 8-isoanalogues of steroid estrogens. G. L. Starova, I. I. Eliseev, Sh. N. Abusalimov, S. B. Tsogoeva, A.G. Shavva. Crystallography Reports. 2001, 46, 65.
6. Study of the molecular structure of 3-methoxy-7α-methyl-8,14-iso-1,3,5(10)-estratrien-17β-ol acetate by x-ray diffraction and molecular modeling methods. G. L. Starova, S. B. Tsogoeva, I. I. Eliseev, A. G. Shavva. Crystallography Reports. 1999, 44, 450.
5. A study of the molecular structure of 3-methoxy-7α-methyl-8,14-iso-1,3,5(10)-estratrien-17β-ol acetate by X-ray diffraction and molecular modeling methods. G. L. Starova, S. B. Tsogoeva, I. I. Eliseev, A. G. Shavva. Kristallografiya, 1999, 44, 490.
4. Ionic hydrogenation of 6-oxaestra-1,3,5(10),8,14-pentaenes. S. B. Tsogoeva, S. I., Selivanov, A. G. Shavva. Russian Journal of Organic Chemistry, 1998, 34, 1297.
3. Molecular structure of (±)-3-methoxy-6-oxa-8-iso-1,3,5(10)-estratrien-17β-ol acetate. G. L. Starova, S. B. Tsogoeva, A. G. Shavva. Kristallografiya, 1998, 43, 36.
2. NMR study of (±)-17β-acetoxy-3-methoxy-6-oxa-8-isoestra-l,3,5(10)-triene. S. I. Selivanov, S. B. Tsogoeva, A. G. Shavva. Russian Journal of Organic Chemistry, 1998, 34, 1292.
1. Molecular structure of (±)-3-methoxy-6-oxa-8-isoestra-1,3,5(10)-trien-17β-ol acetate. G. L. Starova, S. B. Tsogoeva, A. G. Shavva. Crystallography Reports, 1998, 43, 31.